171 related articles for article (PubMed ID: 2571244)
1. Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.
Nolan JC; Stephens DJ; Proakis AG; Leonard CA; Johnson DN; Kilpatrick BF; Foxwell MH; Yanni JM
Agents Actions; 1989 Aug; 28(1-2):53-61. PubMed ID: 2571244
[TBL] [Abstract][Full Text] [Related]
2. Benzo- and pyrido-1,4-oxazepin-5-ones and -thiones: synthesis and structure-activity relationships of a new series of H1 antihistamines.
Cale AD; Gero TW; Walker KR; Lo YS; Welstead WJ; Jaques LW; Johnson AF; Leonard CA; Nolan JC; Johnson DN
J Med Chem; 1989 Sep; 32(9):2178-99. PubMed ID: 2570152
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic analysis of LY188695 (KB-2413), 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole difumarate, a potent histamine1 receptor antagonist.
Fleisch JH; Rinkema LE; Haisch KD; Whitesitt CA
Agents Actions; 1987 Feb; 20(1-2):40-9. PubMed ID: 2883850
[TBL] [Abstract][Full Text] [Related]
4. Effects of nonsedating histamine H1-antagonists on EEG activity and behavior in the cat.
Marzanatti M; Monopoli A; Trampus M; Ongini E
Pharmacol Biochem Behav; 1989 Apr; 32(4):861-6. PubMed ID: 2572005
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo studies of the non-sedating antihistamine epinastine.
Fügner A; Bechtel WD; Kuhn FJ; Mierau J
Arzneimittelforschung; 1988 Oct; 38(10):1446-53. PubMed ID: 2461715
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacokinetics of H1-receptor antagonists (the antihistamines).
Paton DM; Webster DR
Clin Pharmacokinet; 1985; 10(6):477-97. PubMed ID: 2866055
[TBL] [Abstract][Full Text] [Related]
7. Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
Hey JA; Del Prado M; Cuss FM; Egan RW; Sherwood J; Lin CC; Kreutner W
Clin Exp Allergy; 1995 Oct; 25(10):974-84. PubMed ID: 8556569
[TBL] [Abstract][Full Text] [Related]
8. Optical isomers of rocastine and close analogues: synthesis and H1 antihistaminic activity of its enantiomers and their structural relationship to the classical antihistamines.
Sleevi MC; Cale AD; Gero TW; Jaques LW; Welstead WJ; Johnson AF; Kilpatrick BF; Demian I; Nolan JC; Jenkins H
J Med Chem; 1991 Apr; 34(4):1314-28. PubMed ID: 1673158
[TBL] [Abstract][Full Text] [Related]
9. Effects of histamine H1 receptor antagonists on action potentials in guinea-pig isolated papillary muscles.
Ki I; Inui A; Ito T
Arch Int Pharmacodyn Ther; 1996; 331(1):59-73. PubMed ID: 8896711
[TBL] [Abstract][Full Text] [Related]
10. A kinetic study of the antihistaminic effect of terfenadine.
Cheng HC; Woodward JK
Arzneimittelforschung; 1982; 32(9a):1160-6. PubMed ID: 6129862
[TBL] [Abstract][Full Text] [Related]
11. Cardiac electrophysiological actions of the histamine H1-receptor antagonists astemizole and terfenadine compared with chlorpheniramine and pyrilamine.
Salata JJ; Jurkiewicz NK; Wallace AA; Stupienski RF; Guinosso PJ; Lynch JJ
Circ Res; 1995 Jan; 76(1):110-9. PubMed ID: 8001268
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of the cardiotoxicity proclivities of second generation antihistamines in an experimental model predictive of adverse clinical ECG effects.
Hey JA; del Prado M; Sherwood J; Kreutner W; Egan RW
Arzneimittelforschung; 1996 Feb; 46(2):153-8. PubMed ID: 8720304
[TBL] [Abstract][Full Text] [Related]
13. EFFECTS OF HISTAMINE AND RELATED COMPOUNDS ON THE BOVINE IRIS DILATOR.
KAMEI CH
Methods Find Exp Clin Pharmacol; 1996 May; 18(4):273-8. PubMed ID: 8803959
[TBL] [Abstract][Full Text] [Related]
14. AHR-14310C: a potent, long-acting, nonsedating H1-antihistamine that prevents antigen-induced mucus formation in sensitive rats.
Nolan JC; Foxwell MH; Whitman LL; Yanni JM; Walsh DA; Kilpatrick BF; Johnson DN; Proakis AG
J Pharmacol Exp Ther; 1990 Jun; 253(3):1177-83. PubMed ID: 1972750
[TBL] [Abstract][Full Text] [Related]
15. VUF-K-8788, a periphery-selective histamine H1 antagonist with anti-pruritic activities.
Takizawa T; Matsumoto J; Tohma T; Kanke T; Wada Y; Nagao M; Inagaki N; Nagai H; Zhang MQ; Timmerman H
Jpn J Pharmacol; 2001 May; 86(1):55-64. PubMed ID: 11430473
[TBL] [Abstract][Full Text] [Related]
16. Slow wave sleep-inducing effects of first generation H1-antagonists.
Saitou K; Kaneko Y; Sugimoto Y; Chen Z; Kamei C
Biol Pharm Bull; 1999 Oct; 22(10):1079-82. PubMed ID: 10549859
[TBL] [Abstract][Full Text] [Related]
17. The in vivo and in vitro activity of AHR-13268D, a new antiallergic/antihistaminic agent.
Nolan JC; Foxwell MH; Whitman LL; Johnson DN; Yanni JM; Greene SV
Agents Actions; 1990 Nov; 31(3-4):210-8. PubMed ID: 1982201
[TBL] [Abstract][Full Text] [Related]
18. Effects of chlorpheniramine, pyrilamine and astemizole on intracranial self-stimulation in rats.
Wauquier A; Niemegeers CJ
Eur J Pharmacol; 1981 Jun; 72(2-3):245-8. PubMed ID: 6113975
[TBL] [Abstract][Full Text] [Related]
19. Effect of 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimida zole difumarate (KB-2413), a new antiallergic, on chemical mediators.
Fukuda T; Morimoto Y; Iemura R; Kawashima T; Tsukamoto G; Ito K
Arzneimittelforschung; 1984; 34(7):801-5. PubMed ID: 6149754
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of peripheral histamine responses by loratadine and terfenadine.
Mauser PJ; Kreutner W; Egan RW; Chapman RW
Eur J Pharmacol; 1990 Jun; 182(1):125-9. PubMed ID: 1698159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
